CNS Pharmaceuticals Inc.

NASDAQ: CNSP · Real-Time Price · USD
5.97
0.88 (17.29%)
At close: Aug 18, 2025, 3:07 PM

CNS Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
6.46M 548.72K 10.06M 5M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
36.43K 104.75K 482.81K 1.26M
Receivables
882.54K n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.31M 202.86K n/a n/a
Total Current Assets
8.66M 1.59M 12.56M 7.48M
Property-Plant & Equipment
6K 4.93K 5.66K 16.11K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
42.44K 109.68K 488.47K 1.28M
Total Assets
8.7M 1.7M 13.05M 8.76M
Account Payables
2.2M 5.83M 3.68M 1.98M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
326.07K 300.81K 409.97K 387.79K
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
2.52M 6.13M 4.92M 2.59M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a n/a
Total Liabilities
2.52M 6.13M 4.92M 2.14M
Total Debt
326.07K 300.81K 409.97K 387.79K
Common Stock
1.41K 6.21K 1.62K 27.93K
Retained Earnings
-84.42M -69.57M -50.72M -34.98M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
6.18M -4.43M 8.13M 6.62M
Total Investments
n/a n/a n/a n/a